Deciphering the metabolic-epigenetic-immune crosstalk in Epstein-Barr virus-positive nasopharyngeal carcinoma: mechanisms and novel therapeutic frontiers
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Epstein-Barr Virus (EBV) drives Nasopharyngeal Carcinoma (NPC) through metabolic and epigenetic changes. This review explores EBV-NPC mechanisms and novel AI and nanotechnology treatments.
Area Of Science
- Oncology
- Virology
- Epigenetics
Background
- Epstein-Barr Virus (EBV) is linked to significant cancer development, particularly Nasopharyngeal Carcinoma (NPC).
- EBV-associated NPC represents 60% of global cases, with high incidence in South China, Southeast Asia, and North Africa.
- Poor treatment outcomes in NPC are due to subtle early symptoms and resistance.
Purpose Of The Study
- To review pathogenic mechanisms, including metabolic reprogramming and microRNA-driven epigenetic changes, in EBV-positive NPC.
- To analyze the causes of EBV-driven NPC.
- To explore future NPC treatment trends using AI and nanotechnology.
Main Methods
- Comprehensive literature review of EBV-associated NPC.
- Analysis of metabolic, epigenetic, and microRNA interactions in EBV-NPC.
- Exploration of emerging technologies like AI and nanotechnology in NPC treatment.
Main Results
- EBV infection triggers metabolic reprogramming and epigenetic alterations in NPC.
- MicroRNAs play a crucial role in the pathogenesis of EBV-driven NPC.
- Existing studies often lack specificity in understanding the complex EBV-NPC network.
Conclusions
- Understanding the metabolic-epigenetic-immune network is key to combating EBV-NPC.
- Artificial intelligence and nanotechnology offer promising avenues for future NPC therapies.
- Integrated approaches combining novel technologies with clinical treatments are essential for improving NPC patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.